The study identifies lower potassium isotope ratios in Alzheimer’s patients, suggesting δ41K as a viable biomarker for early detection of the disease.
Cosmochemistry techniques shed light on potential new Alzheimer’s disease biomarker
- Post author:
- Post published:September 9, 2024
- Post category:uncategorized